Author

Ashna Reyaz

Indian Institute of Technology Kanpur

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Research Focus:protein structure prediction· 1 Assay:proteomics· 1 Assay:structural biology· 1

Frequent Co-Authors

Andy ChevignéiD· 2 shared Arun K. ShuklaiD· 2 shared Manisankar Ganguly· 2 shared Max MeyrathiD· 2 shared Nilanjana BanerjeeiD· 2 shared Ramanuj BanerjeeiD· 2 shared Alwin Huitema· 1 shared Annu Dalal· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Andy ChevignéORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The FDA-approved CDK4/6 inhibitor Abemaciclib is a potent agonist of the β-arrestin-biased atypical chemokine receptor ACKR3

Maurice C.M.L. Buzink, Joy Darcis, Desislava Nesheva, Max Meyrath, Shawn Jenjak, Nilanjana Banerjee, Manisankar Ganguly, Ashna Reyaz, Ramanuj Banerjee, Esther A. Leliveld, Yong-Jun Kwon, Jerome Paggetti, Sybrand Zielhuis, Dick Pluim, Alwin Huitema, , Rob Leurs

This paper identifies abemaciclib, an FDA-approved CDK4/6 inhibitor, as a potent agonist of ACKR3, an atypical chemokine receptor, revealing its ability to modulate chemokine availability and receptor activity.

bioRxiv · Nov 4, 2026 · PreprintMolecular Biology

Atypical activation and molecular glue-like dimerization mechanism of an intrinsically-biased chemokine receptor

Nilanjana Banerjee, Manisankar Ganguly, Ashna Reyaz, Sudha Mishra, Annu Dalal, Xue Guo, Xingyu Qiu, Max Meyrath, Christie B. Palmer, Hongchen Guo, Siyuan Song, Shachie Sinha, Nabarun Roy, Debdatta Mukherjee, Divyanshu Tiwari, , Arun K. Shukla

This study reveals an atypical activation mechanism of CXCR7, identifies its role as an opioid receptor, and highlights potential for novel pain therapeutics.

bioRxiv · Oct 30, 2025 · PreprintBiochemistry